| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 105 | 2022 | 2867 | 12.390 |
Why?
|
| Multiple Sclerosis | 97 | 2023 | 3222 | 10.880 |
Why?
|
| Amyotrophic Lateral Sclerosis | 27 | 2020 | 1462 | 4.940 |
Why?
|
| Epstein-Barr Virus Infections | 27 | 2023 | 614 | 4.870 |
Why?
|
| Herpesvirus 4, Human | 22 | 2023 | 1076 | 3.690 |
Why?
|
| Uric Acid | 24 | 2022 | 807 | 3.250 |
Why?
|
| Caffeine | 17 | 2020 | 701 | 3.160 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 16 | 2019 | 158 | 3.020 |
Why?
|
| REM Sleep Behavior Disorder | 8 | 2021 | 108 | 2.940 |
Why?
|
| Vitamin D | 27 | 2022 | 3301 | 2.830 |
Why?
|
| Restless Legs Syndrome | 10 | 2018 | 233 | 2.450 |
Why?
|
| Smoking | 53 | 2022 | 9055 | 2.360 |
Why?
|
| Constipation | 8 | 2021 | 564 | 2.310 |
Why?
|
| Diet | 59 | 2022 | 8048 | 2.270 |
Why?
|
| Risk | 64 | 2020 | 9616 | 2.260 |
Why?
|
| Risk Factors | 217 | 2022 | 74241 | 2.020 |
Why?
|
| Infectious Mononucleosis | 6 | 2014 | 133 | 1.680 |
Why?
|
| Case-Control Studies | 71 | 2021 | 22174 | 1.540 |
Why?
|
| Coffee | 11 | 2013 | 593 | 1.500 |
Why?
|
| Cohort Studies | 113 | 2022 | 41496 | 1.490 |
Why?
|
| Dietary Fats | 25 | 2021 | 1994 | 1.470 |
Why?
|
| Prospective Studies | 158 | 2022 | 54437 | 1.420 |
Why?
|
| Antioxidants | 14 | 2017 | 1667 | 1.380 |
Why?
|
| Coronary Disease | 33 | 2010 | 5921 | 1.300 |
Why?
|
| Olfaction Disorders | 4 | 2020 | 224 | 1.290 |
Why?
|
| Dairy Products | 7 | 2021 | 490 | 1.280 |
Why?
|
| Middle Aged | 252 | 2022 | 220858 | 1.260 |
Why?
|
| Antibodies, Viral | 16 | 2023 | 3149 | 1.260 |
Why?
|
| Dietary Fats, Unsaturated | 9 | 2013 | 224 | 1.250 |
Why?
|
| Vitamin D Deficiency | 11 | 2022 | 1388 | 1.240 |
Why?
|
| Proportional Hazards Models | 49 | 2020 | 12474 | 1.200 |
Why?
|
| Female | 263 | 2022 | 392552 | 1.170 |
Why?
|
| Carotenoids | 10 | 2020 | 621 | 1.160 |
Why?
|
| Humans | 406 | 2023 | 761222 | 1.160 |
Why?
|
| Ascorbic Acid | 10 | 2013 | 654 | 1.150 |
Why?
|
| Adult | 227 | 2022 | 221120 | 1.140 |
Why?
|
| Body Mass Index | 39 | 2022 | 12952 | 1.130 |
Why?
|
| Follow-Up Studies | 94 | 2022 | 39127 | 1.110 |
Why?
|
| Parkinson Disease, Secondary | 4 | 2011 | 122 | 1.110 |
Why?
|
| Vitamin E | 14 | 2011 | 872 | 1.080 |
Why?
|
| Male | 261 | 2022 | 360703 | 1.080 |
Why?
|
| Child Development Disorders, Pervasive | 6 | 2014 | 600 | 1.080 |
Why?
|
| Fatty Acids, Unsaturated | 8 | 2019 | 540 | 1.070 |
Why?
|
| Aged | 186 | 2022 | 169292 | 1.050 |
Why?
|
| Demyelinating Diseases | 5 | 2022 | 352 | 1.010 |
Why?
|
| Dietary Fiber | 14 | 2014 | 758 | 1.000 |
Why?
|
| Prenatal Exposure Delayed Effects | 10 | 2022 | 2517 | 0.990 |
Why?
|
| Depression | 14 | 2014 | 8132 | 0.950 |
Why?
|
| Motor Activity | 9 | 2016 | 2712 | 0.920 |
Why?
|
| Alcohol Drinking | 22 | 2020 | 4027 | 0.870 |
Why?
|
| Sex Characteristics | 11 | 2020 | 2640 | 0.850 |
Why?
|
| Odds Ratio | 34 | 2022 | 9652 | 0.840 |
Why?
|
| Flavonoids | 5 | 2022 | 444 | 0.800 |
Why?
|
| Mothers | 9 | 2022 | 2193 | 0.780 |
Why?
|
| Longitudinal Studies | 31 | 2023 | 14610 | 0.780 |
Why?
|
| Neurofilament Proteins | 3 | 2022 | 334 | 0.780 |
Why?
|
| Incidence | 55 | 2019 | 21366 | 0.770 |
Why?
|
| Early Diagnosis | 4 | 2022 | 1186 | 0.750 |
Why?
|
| Fatty Acids, Omega-3 | 7 | 2014 | 1390 | 0.750 |
Why?
|
| Exercise | 15 | 2022 | 5874 | 0.740 |
Why?
|
| Meat Products | 1 | 2021 | 96 | 0.730 |
Why?
|
| Nurses | 22 | 2021 | 2477 | 0.730 |
Why?
|
| Sphingomyelins | 1 | 2021 | 105 | 0.730 |
Why?
|
| Obesity | 16 | 2022 | 12940 | 0.720 |
Why?
|
| Feeding Behavior | 12 | 2021 | 3183 | 0.720 |
Why?
|
| Glucose Transport Proteins, Facilitative | 2 | 2018 | 58 | 0.720 |
Why?
|
| Contraceptives, Oral, Hormonal | 3 | 2017 | 190 | 0.710 |
Why?
|
| Life Style | 11 | 2019 | 3907 | 0.710 |
Why?
|
| Cytochrome P-450 CYP1A2 | 3 | 2018 | 68 | 0.700 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2012 | 2270 | 0.700 |
Why?
|
| Preconception Care | 1 | 2021 | 141 | 0.690 |
Why?
|
| United States | 101 | 2022 | 72341 | 0.670 |
Why?
|
| Logistic Models | 30 | 2020 | 13249 | 0.650 |
Why?
|
| Disease Progression | 23 | 2022 | 13511 | 0.650 |
Why?
|
| Military Personnel | 8 | 2022 | 1246 | 0.650 |
Why?
|
| Ibuprofen | 3 | 2012 | 229 | 0.650 |
Why?
|
| Reproductive History | 2 | 2011 | 210 | 0.640 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2018 | 15920 | 0.630 |
Why?
|
| Confidence Intervals | 19 | 2011 | 2928 | 0.630 |
Why?
|
| General Practice | 1 | 2020 | 97 | 0.630 |
Why?
|
| Fatty Acids, Omega-6 | 4 | 2014 | 225 | 0.590 |
Why?
|
| Erectile Dysfunction | 3 | 2013 | 444 | 0.570 |
Why?
|
| Environment | 4 | 2016 | 1122 | 0.570 |
Why?
|
| HLA-DR Antigens | 2 | 2010 | 606 | 0.570 |
Why?
|
| Sex Factors | 21 | 2020 | 10553 | 0.570 |
Why?
|
| Phospholipids | 1 | 2021 | 784 | 0.570 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2018 | 213 | 0.550 |
Why?
|
| Diabetes Mellitus | 8 | 2020 | 5842 | 0.540 |
Why?
|
| Folic Acid | 7 | 2017 | 1323 | 0.540 |
Why?
|
| Magnesium | 5 | 2019 | 804 | 0.530 |
Why?
|
| Dietary Supplements | 12 | 2017 | 3410 | 0.530 |
Why?
|
| Sunlight | 3 | 2018 | 337 | 0.530 |
Why?
|
| Diet Surveys | 11 | 2022 | 1161 | 0.530 |
Why?
|
| Health Surveys | 17 | 2018 | 4037 | 0.520 |
Why?
|
| Vegetables | 13 | 2018 | 1192 | 0.520 |
Why?
|
| Beverages | 7 | 2017 | 821 | 0.520 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 269 | 0.520 |
Why?
|
| Child of Impaired Parents | 1 | 2019 | 460 | 0.500 |
Why?
|
| Pesticides | 2 | 2010 | 296 | 0.500 |
Why?
|
| Diethylstilbestrol | 2 | 2018 | 87 | 0.490 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2012 | 57 | 0.490 |
Why?
|
| Fruit | 14 | 2018 | 1158 | 0.480 |
Why?
|
| Appendectomy | 1 | 2018 | 434 | 0.480 |
Why?
|
| Myelitis, Transverse | 1 | 2014 | 40 | 0.480 |
Why?
|
| Vitamin B 6 | 4 | 2005 | 234 | 0.470 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2016 | 291 | 0.470 |
Why?
|
| Milk | 3 | 2021 | 440 | 0.470 |
Why?
|
| Tobacco, Smokeless | 2 | 2005 | 133 | 0.470 |
Why?
|
| Central Nervous System Stimulants | 3 | 2012 | 1176 | 0.460 |
Why?
|
| Suicide | 4 | 2014 | 1602 | 0.450 |
Why?
|
| Age Factors | 26 | 2018 | 18384 | 0.450 |
Why?
|
| Sex Distribution | 8 | 2011 | 2277 | 0.450 |
Why?
|
| Eating | 6 | 2022 | 1535 | 0.450 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2016 | 1010 | 0.430 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2020 | 556 | 0.430 |
Why?
|
| Dementia | 4 | 2021 | 2684 | 0.430 |
Why?
|
| Multivariate Analysis | 34 | 2012 | 12052 | 0.430 |
Why?
|
| Age of Onset | 12 | 2022 | 3307 | 0.430 |
Why?
|
| Blood Donors | 3 | 2006 | 345 | 0.430 |
Why?
|
| Immunoglobulin G | 9 | 2019 | 4537 | 0.430 |
Why?
|
| Interleukin-6 | 3 | 2014 | 3210 | 0.420 |
Why?
|
| Inosine | 5 | 2022 | 129 | 0.420 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2021 | 3417 | 0.420 |
Why?
|
| Metabolome | 2 | 2020 | 989 | 0.420 |
Why?
|
| Maternal Exposure | 6 | 2019 | 1067 | 0.420 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 6 | 2022 | 3707 | 0.420 |
Why?
|
| Vitamin B 12 | 4 | 2004 | 524 | 0.410 |
Why?
|
| Cholesterol, HDL | 6 | 2006 | 1812 | 0.410 |
Why?
|
| Viral Matrix Proteins | 2 | 2012 | 193 | 0.410 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 894 | 0.410 |
Why?
|
| Comorbidity | 16 | 2018 | 10516 | 0.410 |
Why?
|
| Finland | 5 | 2019 | 607 | 0.400 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2014 | 344 | 0.390 |
Why?
|
| alpha-Linolenic Acid | 8 | 2017 | 144 | 0.390 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2013 | 160 | 0.390 |
Why?
|
| Vitamins | 5 | 2022 | 1634 | 0.390 |
Why?
|
| Iron, Dietary | 3 | 2019 | 148 | 0.380 |
Why?
|
| Prevalence | 20 | 2022 | 15721 | 0.380 |
Why?
|
| Pregnancy | 17 | 2022 | 29893 | 0.370 |
Why?
|
| Iron | 6 | 2006 | 1791 | 0.370 |
Why?
|
| C-Reactive Protein | 3 | 2014 | 3821 | 0.370 |
Why?
|
| Vitamin E Deficiency | 1 | 2011 | 30 | 0.370 |
Why?
|
| Interferon-beta | 2 | 2012 | 345 | 0.360 |
Why?
|
| Environmental Exposure | 8 | 2017 | 4479 | 0.360 |
Why?
|
| Nutrition Disorders | 1 | 2011 | 204 | 0.360 |
Why?
|
| Adult Children | 1 | 2011 | 103 | 0.360 |
Why?
|
| Health Personnel | 17 | 2014 | 3337 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2019 | 17897 | 0.360 |
Why?
|
| Neuromyelitis Optica | 1 | 2014 | 264 | 0.360 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2012 | 236 | 0.360 |
Why?
|
| Hypertension | 13 | 2011 | 8536 | 0.350 |
Why?
|
| Estrogens | 2 | 2009 | 1522 | 0.350 |
Why?
|
| Ovulation Induction | 1 | 2012 | 277 | 0.350 |
Why?
|
| Young Adult | 25 | 2022 | 59222 | 0.350 |
Why?
|
| Hepatitis B Vaccines | 2 | 2001 | 177 | 0.340 |
Why?
|
| Seafood | 4 | 2014 | 393 | 0.340 |
Why?
|
| Cytomegalovirus | 4 | 2022 | 750 | 0.340 |
Why?
|
| Diphtheria Toxoid | 1 | 2009 | 26 | 0.330 |
Why?
|
| Genetic Determinism | 1 | 2009 | 10 | 0.330 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2010 | 121 | 0.320 |
Why?
|
| Autoimmunity | 2 | 2015 | 1356 | 0.320 |
Why?
|
| Life Change Events | 2 | 2011 | 952 | 0.320 |
Why?
|
| Energy Intake | 15 | 2021 | 2133 | 0.320 |
Why?
|
| Alopecia | 1 | 2013 | 412 | 0.320 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2009 | 74 | 0.310 |
Why?
|
| Television | 1 | 2011 | 407 | 0.310 |
Why?
|
| Infant Mortality | 3 | 2000 | 752 | 0.310 |
Why?
|
| Tetanus Toxoid | 1 | 2009 | 188 | 0.310 |
Why?
|
| Calcium, Dietary | 6 | 2019 | 529 | 0.310 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2008 | 110 | 0.310 |
Why?
|
| Maternal Age | 3 | 2021 | 809 | 0.310 |
Why?
|
| Viral Proteins | 4 | 2010 | 1798 | 0.310 |
Why?
|
| Adolescent | 33 | 2021 | 88300 | 0.310 |
Why?
|
| Cholesterol, LDL | 6 | 2009 | 2380 | 0.310 |
Why?
|
| Superantigens | 1 | 2008 | 126 | 0.300 |
Why?
|
| Hair Color | 1 | 2009 | 131 | 0.300 |
Why?
|
| Aged, 80 and over | 23 | 2021 | 58952 | 0.300 |
Why?
|
| Women | 1 | 2010 | 224 | 0.300 |
Why?
|
| Menarche | 1 | 2011 | 532 | 0.300 |
Why?
|
| Trans Fatty Acids | 2 | 2006 | 155 | 0.300 |
Why?
|
| Cognition Disorders | 5 | 2018 | 3976 | 0.300 |
Why?
|
| Environmental Pollution | 1 | 2009 | 124 | 0.300 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 390 | 0.300 |
Why?
|
| Registries | 5 | 2019 | 8246 | 0.290 |
Why?
|
| Stroke | 10 | 2014 | 9721 | 0.290 |
Why?
|
| Prenatal Care | 2 | 2009 | 1141 | 0.290 |
Why?
|
| Endogenous Retroviruses | 1 | 2008 | 111 | 0.280 |
Why?
|
| Chlamydophila pneumoniae | 2 | 2004 | 53 | 0.280 |
Why?
|
| Tooth Loss | 4 | 2003 | 200 | 0.280 |
Why?
|
| Recreation | 1 | 2008 | 125 | 0.280 |
Why?
|
| Dietary Carbohydrates | 3 | 2009 | 891 | 0.280 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 691 | 0.280 |
Why?
|
| Acetaminophen | 4 | 2019 | 555 | 0.280 |
Why?
|
| Nutritional Status | 4 | 2012 | 1597 | 0.280 |
Why?
|
| Iron Overload | 2 | 2006 | 239 | 0.270 |
Why?
|
| Receptors, Complement 3d | 1 | 2007 | 117 | 0.270 |
Why?
|
| Perinatal Care | 1 | 2009 | 244 | 0.270 |
Why?
|
| Fatty Acids | 7 | 2009 | 1807 | 0.270 |
Why?
|
| Body Size | 1 | 2009 | 463 | 0.270 |
Why?
|
| Neuroprotective Agents | 4 | 2020 | 956 | 0.270 |
Why?
|
| Risk Assessment | 20 | 2012 | 24022 | 0.270 |
Why?
|
| Monoamine Oxidase | 2 | 2008 | 182 | 0.270 |
Why?
|
| Cross Reactions | 1 | 2008 | 819 | 0.270 |
Why?
|
| Meat | 7 | 2021 | 584 | 0.260 |
Why?
|
| Infertility, Female | 1 | 2012 | 761 | 0.260 |
Why?
|
| Antidepressive Agents | 4 | 2014 | 2893 | 0.260 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3952 | 0.260 |
Why?
|
| Cognition | 6 | 2020 | 6988 | 0.250 |
Why?
|
| Phobic Disorders | 3 | 2004 | 439 | 0.250 |
Why?
|
| Hypercholesterolemia | 3 | 2012 | 1141 | 0.250 |
Why?
|
| Wine | 4 | 2012 | 166 | 0.250 |
Why?
|
| Polymorphism, Genetic | 2 | 2009 | 4243 | 0.250 |
Why?
|
| Plant Oils | 4 | 2007 | 198 | 0.250 |
Why?
|
| Hyperuricemia | 2 | 2008 | 222 | 0.250 |
Why?
|
| Sodium, Dietary | 3 | 2017 | 425 | 0.240 |
Why?
|
| Genotype | 9 | 2018 | 12985 | 0.240 |
Why?
|
| Nutritional Physiological Phenomena | 4 | 2006 | 361 | 0.240 |
Why?
|
| Chlamydophila Infections | 1 | 2004 | 23 | 0.230 |
Why?
|
| Severity of Illness Index | 9 | 2021 | 15841 | 0.230 |
Why?
|
| beta Carotene | 5 | 2002 | 523 | 0.230 |
Why?
|
| Cerebrovascular Disorders | 5 | 1999 | 1474 | 0.230 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2010 | 1208 | 0.230 |
Why?
|
| Causality | 5 | 2021 | 1244 | 0.220 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2004 | 251 | 0.220 |
Why?
|
| Regression Analysis | 9 | 2013 | 6345 | 0.220 |
Why?
|
| Awareness | 1 | 2008 | 649 | 0.220 |
Why?
|
| Potassium, Dietary | 3 | 2019 | 102 | 0.220 |
Why?
|
| Functional Laterality | 2 | 2012 | 2257 | 0.220 |
Why?
|
| Postural Balance | 1 | 2008 | 623 | 0.220 |
Why?
|
| Tobacco Use Disorder | 2 | 2007 | 703 | 0.210 |
Why?
|
| Occupations | 1 | 2005 | 517 | 0.210 |
Why?
|
| Myocardial Infarction | 15 | 2006 | 11476 | 0.210 |
Why?
|
| Food | 1 | 2008 | 768 | 0.210 |
Why?
|
| Cross-Sectional Studies | 16 | 2021 | 26072 | 0.210 |
Why?
|
| Periodontal Diseases | 3 | 2003 | 450 | 0.210 |
Why?
|
| Military Medicine | 1 | 2005 | 184 | 0.210 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 3 | 2021 | 415 | 0.210 |
Why?
|
| Retrospective Studies | 20 | 2021 | 80675 | 0.200 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 2002 | 45 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 2157 | 0.200 |
Why?
|
| Diet, Mediterranean | 2 | 2020 | 738 | 0.200 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 1935 | 0.200 |
Why?
|
| Women's Health | 4 | 2021 | 2070 | 0.200 |
Why?
|
| Cotinine | 2 | 2020 | 206 | 0.200 |
Why?
|
| Air Pollutants | 5 | 2017 | 2889 | 0.200 |
Why?
|
| Depressive Disorder | 2 | 2011 | 3727 | 0.190 |
Why?
|
| Ferritins | 3 | 2001 | 596 | 0.190 |
Why?
|
| Vasectomy | 3 | 1997 | 51 | 0.190 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2208 | 0.190 |
Why?
|
| Metabolomics | 3 | 2020 | 1658 | 0.190 |
Why?
|
| Work Schedule Tolerance | 1 | 2006 | 553 | 0.190 |
Why?
|
| Telomere | 1 | 2008 | 939 | 0.190 |
Why?
|
| Somnambulism | 1 | 2021 | 13 | 0.190 |
Why?
|
| Gene Frequency | 3 | 2018 | 3603 | 0.190 |
Why?
|
| Antiparkinson Agents | 1 | 2002 | 184 | 0.190 |
Why?
|
| Antigens, Viral | 4 | 2010 | 989 | 0.190 |
Why?
|
| Attitude to Health | 2 | 2008 | 2026 | 0.180 |
Why?
|
| Inflammation | 2 | 2013 | 10759 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 4340 | 0.180 |
Why?
|
| Infant, Newborn | 5 | 2017 | 26200 | 0.170 |
Why?
|
| Linear Models | 7 | 2012 | 5869 | 0.170 |
Why?
|
| Dopamine | 5 | 2011 | 1601 | 0.170 |
Why?
|
| Antihypertensive Agents | 2 | 2009 | 2019 | 0.170 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2019 | 370 | 0.170 |
Why?
|
| Age Distribution | 8 | 2010 | 2871 | 0.170 |
Why?
|
| Lipids | 3 | 2020 | 3331 | 0.170 |
Why?
|
| Autoantibodies | 1 | 2008 | 2119 | 0.170 |
Why?
|
| Environmental Pollutants | 1 | 2009 | 1276 | 0.170 |
Why?
|
| Adipose Tissue | 10 | 2005 | 3313 | 0.170 |
Why?
|
| Chlamydia Infections | 1 | 2003 | 364 | 0.160 |
Why?
|
| Phosphatidylcholines | 1 | 2021 | 404 | 0.160 |
Why?
|
| Body Height | 4 | 2021 | 1566 | 0.160 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2003 | 749 | 0.160 |
Why?
|
| Alkaloids | 1 | 2020 | 191 | 0.160 |
Why?
|
| Predictive Value of Tests | 9 | 2014 | 15308 | 0.160 |
Why?
|
| Time Factors | 11 | 2022 | 39957 | 0.160 |
Why?
|
| Cause of Death | 2 | 2000 | 3688 | 0.160 |
Why?
|
| Pregnancy Complications | 4 | 2021 | 2949 | 0.160 |
Why?
|
| Sleep Deprivation | 1 | 2006 | 847 | 0.160 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2010 | 130 | 0.160 |
Why?
|
| Brazil | 5 | 2000 | 1228 | 0.160 |
Why?
|
| Beer | 3 | 2012 | 134 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2022 | 12159 | 0.160 |
Why?
|
| Brain Ischemia | 4 | 2011 | 3032 | 0.160 |
Why?
|
| Autoimmune Diseases | 2 | 2008 | 2244 | 0.160 |
Why?
|
| Chromatography, Liquid | 2 | 2020 | 982 | 0.160 |
Why?
|
| Migraine Disorders | 1 | 2011 | 1701 | 0.160 |
Why?
|
| Videoconferencing | 1 | 2020 | 203 | 0.150 |
Why?
|
| Pets | 1 | 2018 | 46 | 0.150 |
Why?
|
| Carnitine | 1 | 2020 | 252 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2008 | 1167 | 0.150 |
Why?
|
| Air Pollution | 3 | 2017 | 2351 | 0.150 |
Why?
|
| Immunization Programs | 1 | 2021 | 267 | 0.150 |
Why?
|
| Parents | 2 | 2010 | 3564 | 0.150 |
Why?
|
| Occupational Exposure | 2 | 2005 | 1814 | 0.150 |
Why?
|
| B-Lymphocytes | 2 | 2009 | 4744 | 0.150 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2020 | 225 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2007 | 2846 | 0.150 |
Why?
|
| Urban Health Services | 1 | 1999 | 176 | 0.150 |
Why?
|
| Denmark | 3 | 2020 | 770 | 0.150 |
Why?
|
| Anthocyanins | 2 | 2022 | 80 | 0.150 |
Why?
|
| Heme | 2 | 2004 | 313 | 0.150 |
Why?
|
| Public Health | 1 | 2021 | 2672 | 0.150 |
Why?
|
| Italy | 1 | 2020 | 844 | 0.150 |
Why?
|
| Oxidative Stress | 3 | 2017 | 3114 | 0.150 |
Why?
|
| Vitamin A | 3 | 2001 | 612 | 0.140 |
Why?
|
| Minerals | 1 | 2019 | 281 | 0.140 |
Why?
|
| Cooking | 3 | 2007 | 309 | 0.140 |
Why?
|
| Colorimetry | 1 | 2017 | 149 | 0.140 |
Why?
|
| Alcoholic Beverages | 2 | 2012 | 264 | 0.140 |
Why?
|
| Child Nutrition Disorders | 1 | 1999 | 139 | 0.140 |
Why?
|
| Poverty Areas | 1 | 1999 | 263 | 0.140 |
Why?
|
| Occupational Diseases | 1 | 2005 | 1490 | 0.140 |
Why?
|
| Blood Pressure | 5 | 2018 | 8479 | 0.140 |
Why?
|
| Nuts | 1 | 2019 | 264 | 0.140 |
Why?
|
| Dietary Proteins | 2 | 2022 | 951 | 0.140 |
Why?
|
| Child Abuse | 2 | 2018 | 1076 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3245 | 0.140 |
Why?
|
| Anthropometry | 5 | 2011 | 1338 | 0.140 |
Why?
|
| Antimetabolites | 1 | 1997 | 129 | 0.140 |
Why?
|
| India | 4 | 2005 | 2287 | 0.130 |
Why?
|
| Plasma | 1 | 2020 | 586 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2021 | 702 | 0.130 |
Why?
|
| Arteriosclerosis | 2 | 2003 | 1056 | 0.130 |
Why?
|
| Menopause | 2 | 2018 | 1646 | 0.130 |
Why?
|
| Particulate Matter | 3 | 2017 | 2597 | 0.130 |
Why?
|
| Statistics as Topic | 2 | 2017 | 2359 | 0.130 |
Why?
|
| Homocysteine | 3 | 2007 | 637 | 0.130 |
Why?
|
| Quality of Life | 3 | 2021 | 13367 | 0.130 |
Why?
|
| Weight Gain | 3 | 2011 | 2349 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4487 | 0.130 |
Why?
|
| Cholesterol | 2 | 2011 | 2902 | 0.130 |
Why?
|
| Death Certificates | 2 | 2008 | 168 | 0.130 |
Why?
|
| Genetic Variation | 2 | 2010 | 6567 | 0.130 |
Why?
|
| Nicotine | 1 | 2020 | 678 | 0.130 |
Why?
|
| Lipoproteins | 1 | 2000 | 877 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2021 | 3434 | 0.120 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2002 | 830 | 0.120 |
Why?
|
| Postmenopause | 3 | 2017 | 2514 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 2189 | 0.120 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 588 | 0.120 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2009 | 190 | 0.120 |
Why?
|
| Contraceptives, Oral | 2 | 2009 | 554 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2001 | 716 | 0.120 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 264 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2003 | 1160 | 0.120 |
Why?
|
| Body Weight | 4 | 2021 | 4618 | 0.120 |
Why?
|
| Fishes | 2 | 2014 | 600 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9567 | 0.120 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 2569 | 0.120 |
Why?
|
| Margarine | 1 | 1994 | 17 | 0.120 |
Why?
|
| HLA-A Antigens | 1 | 2014 | 223 | 0.110 |
Why?
|
| Haplotypes | 2 | 2011 | 2715 | 0.110 |
Why?
|
| Health Status | 5 | 2021 | 4077 | 0.110 |
Why?
|
| Growth Disorders | 1 | 1999 | 634 | 0.110 |
Why?
|
| Probability | 2 | 2011 | 2478 | 0.110 |
Why?
|
| Nutrition Surveys | 3 | 2007 | 1723 | 0.110 |
Why?
|
| Atrophy | 1 | 2018 | 1633 | 0.110 |
Why?
|
| Antibodies | 2 | 2014 | 2415 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 2133 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 1997 | 342 | 0.110 |
Why?
|
| Child Health Services | 1 | 1999 | 644 | 0.110 |
Why?
|
| Marital Status | 2 | 2011 | 425 | 0.110 |
Why?
|
| Flavonols | 2 | 2012 | 85 | 0.110 |
Why?
|
| Educational Status | 3 | 2012 | 2510 | 0.110 |
Why?
|
| Body Constitution | 4 | 2004 | 273 | 0.100 |
Why?
|
| Metals, Heavy | 1 | 2014 | 148 | 0.100 |
Why?
|
| Rhamnus | 1 | 1992 | 1 | 0.100 |
Why?
|
| Plant Poisoning | 1 | 1992 | 13 | 0.100 |
Why?
|
| Socioeconomic Factors | 6 | 2018 | 7804 | 0.100 |
Why?
|
| Developing Countries | 2 | 2005 | 2863 | 0.100 |
Why?
|
| Citrus sinensis | 1 | 2012 | 15 | 0.100 |
Why?
|
| Plants, Toxic | 1 | 1992 | 71 | 0.100 |
Why?
|
| Flavones | 1 | 2012 | 68 | 0.100 |
Why?
|
| Sodium | 1 | 2017 | 1589 | 0.100 |
Why?
|
| Flavanones | 1 | 2012 | 74 | 0.100 |
Why?
|
| Heterozygote | 3 | 2020 | 2778 | 0.100 |
Why?
|
| Aging | 5 | 2021 | 8702 | 0.100 |
Why?
|
| Disability Evaluation | 3 | 2021 | 1834 | 0.100 |
Why?
|
| Malus | 1 | 2012 | 50 | 0.100 |
Why?
|
| Child | 14 | 2021 | 80154 | 0.100 |
Why?
|
| Blast Injuries | 1 | 1995 | 322 | 0.100 |
Why?
|
| Costa Rica | 7 | 2007 | 180 | 0.100 |
Why?
|
| Community Health Planning | 1 | 2012 | 164 | 0.100 |
Why?
|
| Weight Loss | 1 | 2003 | 2680 | 0.100 |
Why?
|
| Plants, Medicinal | 1 | 1992 | 165 | 0.100 |
Why?
|
| Fathers | 1 | 2014 | 375 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2012 | 4111 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7851 | 0.090 |
Why?
|
| Antirheumatic Agents | 1 | 2021 | 1369 | 0.090 |
Why?
|
| Animals | 16 | 2021 | 168089 | 0.090 |
Why?
|
| Canada | 2 | 2020 | 2125 | 0.090 |
Why?
|
| Brain | 4 | 2018 | 27094 | 0.090 |
Why?
|
| Nutrition Assessment | 3 | 2007 | 727 | 0.090 |
Why?
|
| Antipyretics | 1 | 2011 | 23 | 0.090 |
Why?
|
| Prebiotics | 1 | 2021 | 41 | 0.090 |
Why?
|
| Drug Interactions | 3 | 2005 | 1417 | 0.090 |
Why?
|
| Melanoma | 1 | 2009 | 5694 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 1250 | 0.090 |
Why?
|
| Reference Values | 3 | 2006 | 4921 | 0.090 |
Why?
|
| Radioimmunoassay | 1 | 2011 | 862 | 0.090 |
Why?
|
| Amide Synthases | 1 | 2010 | 14 | 0.090 |
Why?
|
| Dieldrin | 1 | 2010 | 7 | 0.090 |
Why?
|
| Capsid Proteins | 2 | 2004 | 464 | 0.090 |
Why?
|
| Paralysis | 1 | 1992 | 250 | 0.090 |
Why?
|
| Immunoglobulin A | 2 | 2005 | 979 | 0.090 |
Why?
|
| Parity | 2 | 2004 | 929 | 0.090 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2010 | 57 | 0.090 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2003 | 488 | 0.090 |
Why?
|
| Tea | 1 | 2012 | 288 | 0.090 |
Why?
|
| Recurrence | 3 | 2022 | 8457 | 0.090 |
Why?
|
| Particle Size | 1 | 2014 | 1649 | 0.090 |
Why?
|
| Defecation | 1 | 2011 | 190 | 0.080 |
Why?
|
| Aspirin | 4 | 2005 | 3129 | 0.080 |
Why?
|
| Hygiene | 1 | 2010 | 94 | 0.080 |
Why?
|
| Steroid Hydroxylases | 1 | 2009 | 93 | 0.080 |
Why?
|
| Norway | 2 | 2018 | 499 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2014 | 10218 | 0.080 |
Why?
|
| Epidemiologic Studies | 1 | 2013 | 677 | 0.080 |
Why?
|
| Neuropsychological Tests | 5 | 2020 | 7046 | 0.080 |
Why?
|
| Double-Blind Method | 5 | 2021 | 12341 | 0.080 |
Why?
|
| Seasons | 2 | 2018 | 1518 | 0.080 |
Why?
|
| Nails | 2 | 2003 | 296 | 0.080 |
Why?
|
| Cardiovascular Diseases | 7 | 2020 | 15521 | 0.080 |
Why?
|
| Self Report | 2 | 2018 | 3727 | 0.080 |
Why?
|
| Genome-Wide Association Study | 4 | 2020 | 12676 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5250 | 0.080 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 173 | 0.080 |
Why?
|
| Mood Disorders | 2 | 2012 | 1124 | 0.080 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 213 | 0.080 |
Why?
|
| Arteries | 2 | 2003 | 1121 | 0.080 |
Why?
|
| Physicians | 1 | 2006 | 4584 | 0.070 |
Why?
|
| Europe | 2 | 2009 | 3423 | 0.070 |
Why?
|
| Maternal Behavior | 1 | 2010 | 307 | 0.070 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2010 | 431 | 0.070 |
Why?
|
| Myelin Proteins | 1 | 2008 | 212 | 0.070 |
Why?
|
| Social Behavior | 1 | 2014 | 1136 | 0.070 |
Why?
|
| Waist-Hip Ratio | 1 | 2009 | 518 | 0.070 |
Why?
|
| New Zealand | 1 | 2008 | 358 | 0.070 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2012 | 497 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1791 | 0.070 |
Why?
|
| Antibodies, Bacterial | 2 | 2004 | 1464 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 20982 | 0.070 |
Why?
|
| Fertility | 1 | 2012 | 768 | 0.070 |
Why?
|
| Hydrogenation | 2 | 1999 | 20 | 0.070 |
Why?
|
| Health Policy | 1 | 2020 | 2679 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2017 | 2688 | 0.070 |
Why?
|
| Receptors, Calcitriol | 1 | 2009 | 360 | 0.070 |
Why?
|
| Abdominal Fat | 1 | 2009 | 221 | 0.070 |
Why?
|
| Brain Infarction | 1 | 2009 | 289 | 0.070 |
Why?
|
| Probiotics | 1 | 2021 | 378 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2011 | 1636 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 1 | 2008 | 399 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2009 | 6223 | 0.070 |
Why?
|
| Birth Weight | 2 | 2010 | 2104 | 0.070 |
Why?
|
| Prostatic Neoplasms | 7 | 1999 | 11101 | 0.070 |
Why?
|
| Puerto Rico | 1 | 2008 | 378 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2000 | 3200 | 0.070 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2009 | 196 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2010 | 991 | 0.070 |
Why?
|
| Urban Health | 2 | 2007 | 532 | 0.070 |
Why?
|
| Boston | 4 | 2008 | 9327 | 0.070 |
Why?
|
| Encephalitis | 1 | 2010 | 438 | 0.070 |
Why?
|
| Phenols | 1 | 2010 | 517 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 2854 | 0.060 |
Why?
|
| Food Analysis | 2 | 2006 | 103 | 0.060 |
Why?
|
| Perception | 1 | 2012 | 1198 | 0.060 |
Why?
|
| Linoleic Acid | 2 | 2005 | 158 | 0.060 |
Why?
|
| Dietary Sucrose | 1 | 2007 | 243 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 1885 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1472 | 0.060 |
Why?
|
| Arginine | 1 | 2009 | 920 | 0.060 |
Why?
|
| Infant | 7 | 2013 | 36170 | 0.060 |
Why?
|
| Urinalysis | 1 | 2007 | 368 | 0.060 |
Why?
|
| Diet Records | 3 | 2005 | 427 | 0.060 |
Why?
|
| Research | 1 | 2013 | 1976 | 0.060 |
Why?
|
| Neoplasms | 7 | 2011 | 22142 | 0.060 |
Why?
|
| Research Design | 1 | 2020 | 6180 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2010 | 751 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3803 | 0.060 |
Why?
|
| Measles | 2 | 2001 | 181 | 0.060 |
Why?
|
| Psoriasis | 1 | 2012 | 946 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 6506 | 0.060 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 691 | 0.060 |
Why?
|
| Japan | 1 | 2008 | 1378 | 0.060 |
Why?
|
| Cysteine | 1 | 2009 | 888 | 0.060 |
Why?
|
| Hospital Records | 1 | 2004 | 93 | 0.060 |
Why?
|
| Immune System | 1 | 2009 | 792 | 0.060 |
Why?
|
| Autistic Disorder | 1 | 2013 | 1222 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 1527 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 765 | 0.050 |
Why?
|
| ROC Curve | 1 | 2011 | 3584 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 3051 | 0.050 |
Why?
|
| Hormones | 1 | 2007 | 868 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2010 | 917 | 0.050 |
Why?
|
| Population | 1 | 2003 | 141 | 0.050 |
Why?
|
| Morbidity | 1 | 2008 | 1751 | 0.050 |
Why?
|
| Colonic Neoplasms | 4 | 1996 | 2527 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2010 | 2195 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2006 | 285 | 0.050 |
Why?
|
| Massachusetts | 3 | 2017 | 8837 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2009 | 1460 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 1992 | 1747 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2340 | 0.050 |
Why?
|
| gamma-Tocopherol | 1 | 2002 | 30 | 0.050 |
Why?
|
| Epidemiologic Research Design | 1 | 2005 | 368 | 0.050 |
Why?
|
| Child, Preschool | 9 | 2021 | 42225 | 0.050 |
Why?
|
| Epidemiologic Methods | 2 | 2004 | 1336 | 0.050 |
Why?
|
| Distemper | 1 | 2001 | 3 | 0.050 |
Why?
|
| Xanthophylls | 3 | 2002 | 94 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 2468 | 0.050 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2002 | 128 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2002 | 328 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2010 | 2839 | 0.050 |
Why?
|
| Phenotype | 2 | 2009 | 16575 | 0.050 |
Why?
|
| Health Maintenance Organizations | 1 | 2004 | 658 | 0.050 |
Why?
|
| Lutein | 3 | 2002 | 123 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 8002 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2007 | 825 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 10203 | 0.050 |
Why?
|
| Models, Statistical | 3 | 2013 | 5081 | 0.050 |
Why?
|
| Cholesterol, Dietary | 2 | 2003 | 224 | 0.050 |
Why?
|
| Birth Order | 1 | 2001 | 95 | 0.050 |
Why?
|
| Forearm Injuries | 2 | 1998 | 68 | 0.050 |
Why?
|
| Adenoma | 4 | 1995 | 2159 | 0.040 |
Why?
|
| Selenium | 1 | 2003 | 416 | 0.040 |
Why?
|
| Iowa | 1 | 2000 | 104 | 0.040 |
Why?
|
| Xanthines | 1 | 2020 | 120 | 0.040 |
Why?
|
| Theophylline | 1 | 2020 | 131 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 36415 | 0.040 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 180 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 1603 | 0.040 |
Why?
|
| Medicine, Traditional | 1 | 2000 | 88 | 0.040 |
Why?
|
| California | 1 | 2004 | 1431 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2007 | 10756 | 0.040 |
Why?
|
| Mexico | 1 | 2002 | 757 | 0.040 |
Why?
|
| Mortality | 2 | 2001 | 2896 | 0.040 |
Why?
|
| Sputum | 1 | 2002 | 505 | 0.040 |
Why?
|
| Phosphorus, Dietary | 1 | 2019 | 20 | 0.040 |
Why?
|
| Vaccination | 3 | 2021 | 3369 | 0.040 |
Why?
|
| Scotland | 1 | 2019 | 143 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2019 | 64681 | 0.040 |
Why?
|
| Hip Fractures | 2 | 1998 | 989 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2006 | 1560 | 0.040 |
Why?
|
| Colles' Fracture | 1 | 1998 | 11 | 0.040 |
Why?
|
| Sanitation | 1 | 1999 | 82 | 0.040 |
Why?
|
| Sports | 1 | 2005 | 705 | 0.040 |
Why?
|
| Fluoridation | 1 | 1998 | 29 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6486 | 0.040 |
Why?
|
| Estradiol | 1 | 2006 | 1937 | 0.040 |
Why?
|
| Family | 1 | 2009 | 3192 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2004 | 915 | 0.040 |
Why?
|
| Urbanization | 1 | 1999 | 100 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2002 | 461 | 0.040 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2018 | 52 | 0.040 |
Why?
|
| Time | 1 | 2020 | 545 | 0.040 |
Why?
|
| Data Collection | 2 | 2005 | 3320 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3691 | 0.040 |
Why?
|
| Mozambique | 2 | 1995 | 55 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2017 | 8606 | 0.040 |
Why?
|
| Snoring | 1 | 1999 | 209 | 0.040 |
Why?
|
| Eggs | 1 | 1999 | 182 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 481 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2005 | 2691 | 0.040 |
Why?
|
| Fluorides | 1 | 1998 | 134 | 0.040 |
Why?
|
| Cuba | 1 | 1997 | 48 | 0.040 |
Why?
|
| Employment | 1 | 2004 | 1114 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2008 | 10088 | 0.040 |
Why?
|
| Validation Studies as Topic | 1 | 2017 | 162 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2003 | 1111 | 0.040 |
Why?
|
| Kidney Calculi | 1 | 2021 | 463 | 0.030 |
Why?
|
| Femoral Neck Fractures | 1 | 1998 | 142 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 12976 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 4851 | 0.030 |
Why?
|
| Nutrition Policy | 1 | 2000 | 466 | 0.030 |
Why?
|
| Thiamine Deficiency | 1 | 1997 | 48 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2012 | 1130 | 0.030 |
Why?
|
| Copper | 1 | 2019 | 366 | 0.030 |
Why?
|
| Fats, Unsaturated | 1 | 1996 | 21 | 0.030 |
Why?
|
| Cities | 1 | 1999 | 541 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 3788 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3571 | 0.030 |
Why?
|
| Gout Suppressants | 1 | 2018 | 177 | 0.030 |
Why?
|
| Manganese | 1 | 2019 | 391 | 0.030 |
Why?
|
| Dogs | 1 | 2001 | 3832 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 461 | 0.030 |
Why?
|
| Alleles | 2 | 2009 | 6857 | 0.030 |
Why?
|
| Thiamine | 1 | 1997 | 160 | 0.030 |
Why?
|
| Fructose | 1 | 1998 | 285 | 0.030 |
Why?
|
| Viral Vaccines | 1 | 2021 | 593 | 0.030 |
Why?
|
| Oral Health | 2 | 2003 | 491 | 0.030 |
Why?
|
| Viral Load | 1 | 2004 | 3328 | 0.030 |
Why?
|
| Fractures, Bone | 2 | 1998 | 2046 | 0.030 |
Why?
|
| Wrist Injuries | 1 | 1998 | 214 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6067 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2001 | 828 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2021 | 2643 | 0.030 |
Why?
|
| Diverticulum, Colon | 1 | 1995 | 32 | 0.030 |
Why?
|
| Zinc | 1 | 2019 | 672 | 0.030 |
Why?
|
| Demography | 1 | 1999 | 1641 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2020 | 988 | 0.030 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2020 | 821 | 0.030 |
Why?
|
| Lipoprotein(a) | 1 | 1999 | 482 | 0.030 |
Why?
|
| Smoking Cessation | 2 | 2007 | 2056 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 30004 | 0.030 |
Why?
|
| Asia | 1 | 1996 | 622 | 0.030 |
Why?
|
| Amputation, Traumatic | 1 | 1995 | 135 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 18222 | 0.030 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 2 | 2008 | 254 | 0.030 |
Why?
|
| Diarrhea | 1 | 2000 | 1316 | 0.030 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2001 | 1372 | 0.030 |
Why?
|
| Random Allocation | 2 | 2014 | 2393 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14675 | 0.030 |
Why?
|
| Corpus Striatum | 2 | 2012 | 1234 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2000 | 2697 | 0.030 |
Why?
|
| Agnosia | 1 | 2013 | 66 | 0.030 |
Why?
|
| Colonic Polyps | 2 | 1995 | 552 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2018 | 1078 | 0.030 |
Why?
|
| Brain Injury, Chronic | 1 | 2013 | 68 | 0.030 |
Why?
|
| Transferrin | 1 | 1994 | 283 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2004 | 2877 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 1009 | 0.030 |
Why?
|
| Needs Assessment | 1 | 1999 | 1141 | 0.030 |
Why?
|
| Iraq | 1 | 1992 | 92 | 0.030 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 1992 | 9 | 0.030 |
Why?
|
| Nicaragua | 1 | 1992 | 29 | 0.030 |
Why?
|
| Methionine | 1 | 1995 | 570 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2003 | 2598 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 6011 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2005 | 20118 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2012 | 314 | 0.020 |
Why?
|
| Urban Population | 1 | 2000 | 2036 | 0.020 |
Why?
|
| Tocopherols | 1 | 2011 | 44 | 0.020 |
Why?
|
| Selegiline | 1 | 2011 | 32 | 0.020 |
Why?
|
| Tropanes | 1 | 2011 | 48 | 0.020 |
Why?
|
| Food Labeling | 1 | 1994 | 179 | 0.020 |
Why?
|
| Patient Selection | 1 | 2003 | 4246 | 0.020 |
Why?
|
| Poliomyelitis | 1 | 1992 | 92 | 0.020 |
Why?
|
| Motivation | 1 | 2021 | 2002 | 0.020 |
Why?
|
| Arsenic | 1 | 2014 | 361 | 0.020 |
Why?
|
| Breast Feeding | 1 | 1999 | 1356 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2012 | 639 | 0.020 |
Why?
|
| Overweight | 1 | 2021 | 2418 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2004 | 12747 | 0.020 |
Why?
|
| Measles Vaccine | 1 | 1990 | 79 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 14025 | 0.020 |
Why?
|
| Osteoporosis | 1 | 1998 | 1604 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 590 | 0.020 |
Why?
|
| Indans | 1 | 2008 | 92 | 0.020 |
Why?
|
| Nootropic Agents | 1 | 2008 | 157 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2001 | 6387 | 0.020 |
Why?
|
| Cocaine | 1 | 2012 | 958 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2021 | 4384 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 2 | 2000 | 998 | 0.020 |
Why?
|
| Survival Rate | 2 | 1999 | 12728 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 29688 | 0.020 |
Why?
|
| Mental Health | 1 | 2021 | 3251 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2006 | 63 | 0.020 |
Why?
|
| Social Support | 1 | 1996 | 2175 | 0.020 |
Why?
|
| Health Behavior | 1 | 2017 | 2641 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2018 | 7965 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2000 | 9319 | 0.020 |
Why?
|
| Rural Health | 1 | 2007 | 296 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 4642 | 0.020 |
Why?
|
| Drug Implants | 1 | 2006 | 230 | 0.020 |
Why?
|
| Fatty Acids, Essential | 1 | 2005 | 97 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2010 | 1994 | 0.020 |
Why?
|
| Soybean Oil | 1 | 2005 | 139 | 0.010 |
Why?
|
| Calcium | 1 | 1998 | 5719 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2011 | 941 | 0.010 |
Why?
|
| Colorectal Neoplasms | 2 | 1994 | 6919 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 13386 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2004 | 346 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2006 | 614 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14392 | 0.010 |
Why?
|
| Acute Disease | 1 | 1994 | 7226 | 0.010 |
Why?
|
| Methylation | 1 | 2006 | 1070 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 2684 | 0.010 |
Why?
|
| Toes | 1 | 2003 | 209 | 0.010 |
Why?
|
| Mental Recall | 2 | 2001 | 1221 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1996 | 8642 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1997 | 6392 | 0.010 |
Why?
|
| Health Occupations | 2 | 1994 | 223 | 0.010 |
Why?
|
| Cholesterol, VLDL | 1 | 2002 | 70 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2007 | 1381 | 0.010 |
Why?
|
| Telephone | 1 | 2005 | 624 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2004 | 1018 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2113 | 0.010 |
Why?
|
| Fish Oils | 1 | 2005 | 483 | 0.010 |
Why?
|
| Gout | 1 | 2008 | 621 | 0.010 |
Why?
|
| Physical Fitness | 2 | 1996 | 742 | 0.010 |
Why?
|
| Piperidines | 1 | 2008 | 1656 | 0.010 |
Why?
|
| Citrus | 1 | 1999 | 49 | 0.010 |
Why?
|
| Allied Health Personnel | 1 | 2000 | 154 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 2425 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 3089 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2011 | 2795 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2263 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 6974 | 0.010 |
Why?
|
| Dental Health Surveys | 1 | 1996 | 39 | 0.010 |
Why?
|
| DMF Index | 1 | 1996 | 87 | 0.010 |
Why?
|
| Mice | 2 | 2018 | 81330 | 0.010 |
Why?
|
| Insulin | 1 | 2010 | 6588 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1996 | 311 | 0.010 |
Why?
|
| Accidents | 1 | 1996 | 165 | 0.010 |
Why?
|
| Fasting | 1 | 2001 | 1603 | 0.010 |
Why?
|
| Dentists | 1 | 1996 | 176 | 0.010 |
Why?
|
| Food Preferences | 1 | 1998 | 398 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 763 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 2219 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 1994 | 151 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1995 | 1150 | 0.010 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1990 | 59 | 0.010 |
Why?
|
| Medical Records | 1 | 1996 | 1409 | 0.010 |
Why?
|
| Rectum | 1 | 1995 | 891 | 0.010 |
Why?
|
| Biopsy | 1 | 2001 | 6781 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 22128 | 0.000 |
Why?
|
| Models, Biological | 1 | 2003 | 9458 | 0.000 |
Why?
|
| Colonoscopy | 1 | 1994 | 1395 | 0.000 |
Why?
|
| Heart Rate | 1 | 1996 | 4197 | 0.000 |
Why?
|
| Carcinoma | 1 | 1995 | 2330 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 11119 | 0.000 |
Why?
|
| Cluster Analysis | 1 | 1990 | 2706 | 0.000 |
Why?
|